Your session is about to expire
← Back to Search
Low-Level Laser Therapy for Plantar Fasciitis
Study Summary
This trial aims to evaluate a new therapy to reduce pain and disability from foot injury in service members. Results will help inform best practices for treating foot-related issues.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have nerve damage or can't feel changes in skin temperature.I experience pain in my foot or heel at some point during the day.I have had injections, surgery, or other treatments for my condition before.I have had a traumatic injury to my foot or feet that still causes symptoms.I am not taking medications that make me sensitive to heat or light.I have been diagnosed with Plantar Fasciitis by a doctor.I have had symptoms of pulmonary fibrosis for at least 3 months.I can commit to a 6-week study and follow-ups at 3 and 6 months.
- Group 1: The Usual Care + PBM Group
- Group 2: The Usual Care + Sham (Placebo) PBM Group
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the participant population for this experiment restricted to those older than 35?
"This clinical trial stipulates that the minimum age of participants is 18, while those over 54 years old are not eligible for inclusion."
Who has the suitable criteria to be considered for enrollment in this research study?
"This study has stringent eligibility criteria; the ideal candidate must have a diagnosis of plantar fasciitis, and be younger than 55 years old. The trial aims to enroll 100 volunteers in total."
Are there any remaining participation opportunities for subjects in this trial?
"Affirmative. The data published on clinicaltrials.gov suggests that this study, which was initially advertised on August 11th 2022 and has been recently updated in March 8th 2023, is actively looking for 100 patients at a single site."
What is the cap for participants in this experiment?
"Affirmative. According to clinicaltrials.gov, the current recruitment phase is active with postings beginning on August 11th 2022 and being recently updated on March 8th 2023. This medical research requires 100 participants from a single location."
Share this study with friends
Copy Link
Messenger